Breast cancer is one of the leading causes of cancer-related morbidity and mortality in women worldwide. Early diagnosis and effective treatment of all types of cancers are crucial …
D Iacopetta, J Ceramella, N Baldino… - International Journal of …, 2023 - mdpi.com
Breast cancer (BC) is one of the most widely diagnosed cancers and a leading cause of cancer death among women worldwide. Globally, BC is the second most frequent cancer …
EG Mills, L Yang, MF Nielsen, M Kassem… - Endocrine …, 2021 - academic.oup.com
Reproductive hormones play a crucial role in the growth and maintenance of the mammalian skeleton. Indeed, the biological significance for this hormonal regulation of …
M Poutanen, M Hagberg Thulin, P Härkönen - Nature Reviews Cancer, 2023 - nature.com
Sex steroids are major promoters of the growth of breast and prostate cancers. This Review by Poutanen et al. describes the development of treatments for these cancer types that act to …
The journey of chemotherapeutic drugs from the site of administration to the site of action is confronted by several factors including low bioavailability, uneven distribution in major …
MP Garrido, A Hernandez, M Vega, E Araya… - Frontiers in …, 2023 - frontiersin.org
For many years, luteinizing hormone-releasing hormone or gonadotropin-releasing hormone (GnRH) analogs have been used to treat androgen or estrogen-dependent tumors …
G Valsamakis, K Valtetsiotis, E Charmandari… - International journal of …, 2022 - mdpi.com
In this review, we analyzed existing literature regarding the use of Gonadotropin-releasing Hormone (GnRH) analogues (agonists, antagonists) as a co-treatment to chemotherapy and …
P Fanis, V Neocleous, I Papapetrou… - International Journal of …, 2023 - mdpi.com
Human sexual and reproductive development is regulated by the hypothalamic-pituitary- gonadal (HPG) axis, which is primarily controlled by the gonadotropin-releasing hormone …
YS Lu, A Wong, HJ Kim - Frontiers in Oncology, 2021 - frontiersin.org
Chemotherapy and endocrine therapies are mainstays of treatment for early and advanced hormone receptor-positive (HR+) breast cancer. In premenopausal women with HR+ tumors …